Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO3 pseudogene 16 (MTCO3P16) is annotated as a pseudogene, meaning it is a non-functional genomic sequence related to the gene encoding cytochrome c oxidase subunit III[3]. Pseudogenes are typically regarded as molecular fossils, with no protein product and no established function as a receptor, enzyme, or drug target. MTCO3P16 is not considered a therapeutic target, does not encode a protein, and lacks associations with disease or drug response. Its alternative name, "ALS2CR3," and its relationship to mitochondrial genes may cause confusion, but the functional gene is MT-CO3, not MTCO3P16[3].\n\nNote: MTCO3P16 is correctly classified as a pseudogene, not a receptor, enzyme, or genuine therapeutic target. Any query or annotation treating it as a functional target would be incorrect[3]. The relevant, functional protein-coding gene is *MT-CO3* (cytochrome c oxidase subunit III), not this pseudogene[1][2][5][7].
null (not a target for therapeutic intervention)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO3 pseudogene 16 (MTCO3P16).